Your browser doesn't support javascript.
loading
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes.
Stuckey, Ruth; Casado, Luis-Felipe; Colomer, Dolors; Gómez-Casares, María Teresa; Casas, Laura; García-Gutierrez, Valentín; Sastre, José Luis; Ramírez-Payer, Ángel; Vall-Llovera, Ferrán; Goñi, María Ángeles; Xicoy, Blanca; Godoy, Ana Cristina; Núñez, Javier; Mora, Itxaso; Vallansot, Rolando; López-Lorenzo, José Luis; Palomera, Luis; Conesa, Venancio; Noya, María Soledad; Sánchez-Guijo, Fermín; Peña, Ascensión; Bautista, Guiomar; Steegmann, Juan Luis.
Afiliação
  • Stuckey R; Department of Hematology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
  • Casado LF; Department of Hematology, Hospital Virgen de la Salud, Toledo, Spain.
  • Colomer D; Hematopathology Unit, Hospital Clinic Universitari, Barcelona, Spain.
  • Gómez-Casares MT; Department of Hematology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
  • Casas L; Dynamics Solutions, Madrid, Spain.
  • García-Gutierrez V; Ramón y Cajal Health Research Institute, Hospital Ramón y Cajal, Madrid, Spain.
  • Sastre JL; Department of Hematology, Hospital Universitario de Orense, Orense, Spain.
  • Ramírez-Payer Á; Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Vall-Llovera F; Department of Hematology, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
  • Goñi MÁ; Department of Hematology, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Xicoy B; Department of Hematology, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Godoy AC; Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain.
  • Núñez J; Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Mora I; Department of Hematology, Complejo Hospitalario de Navarra, Navarra, Spain.
  • Vallansot R; Hematology Service, Hospital Universitari Joan XXIII, Tarragona, Spain.
  • López-Lorenzo JL; Department of Hematology, Hospital Fundación Jiménez Diaz, Madrid, Spain.
  • Palomera L; Aragón Institute of Health Investigation, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Conesa V; Department of Hematology, Hospital General Universitario de Elche, Elche, Spain.
  • Noya MS; Department of Hematology, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Sánchez-Guijo F; Department of Hematology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
  • Peña A; Department of Hematology, Hospital Clínico de San Carlos, Madrid, Spain.
  • Bautista G; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Steegmann JL; Department of Hematology, Hospital de la Princesa, Madrid, Spain. Electronic address: jlsteegmann.hlpr@salud.madrid.org.
J Mol Diagn ; 22(10): 1217-1224, 2020 10.
Article em En | MEDLINE | ID: mdl-32688056

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas Proto-Oncogênicas c-abl / Proteínas de Fusão bcr-abl / Glucuronidase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas Proto-Oncogênicas c-abl / Proteínas de Fusão bcr-abl / Glucuronidase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha